EDESA BIOTECH, INC. Operating Expenses
EDESA BIOTECH, INC. (EDSA) reported Operating Expenses of $9.51 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-05-14
- EDESA BIOTECH, INC. operating expenses for the quarter ending 2021-03-31 was $9.51M, a 484.62% increase year-over-year.
- EDESA BIOTECH, INC. operating expenses for the quarter ending 2020-12-31 was $2.61M, a 115.40% increase year-over-year.
- EDESA BIOTECH, INC. operating expenses for the quarter ending 2020-09-30 was $2.01M, a 45.58% increase year-over-year.
- EDESA BIOTECH, INC. operating expenses for the quarter ending 2020-06-30 was $1.88M, a 42.21% increase year-over-year.
- EDESA BIOTECH, INC. operating expenses for fiscal 2020 was $6.73M.
- EDESA BIOTECH, INC. operating expenses for fiscal 2018 was $1.62M.
- EDESA BIOTECH, INC. operating expenses for fiscal 2018 was $5.29M, a 2.98% decline from fiscal 2017.
- EDESA BIOTECH, INC. operating expenses for fiscal 2017 was $5.45M, a 11.77% decline from fiscal 2016.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | $9.51M 10-Q · filed 2021-05-14 | $12.12M 10-Q · filed 2021-05-14 | $14.14M derived: sum of 3 quarters · filed 2021-05-14 | $16.01M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2020-12-31 | $2.61M 10-Q · filed 2021-02-16 | $4.62M derived: sum of 2 quarters · filed 2021-02-16 | $6.50M derived: sum of 3 quarters · filed 2021-02-16 | $8.13M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2020-09-30 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-07 | $3.89M derived: sum of 2 quarters · filed 2020-12-07 | $5.52M derived: sum of 3 quarters · filed 2021-05-14 | $6.73M 10-K · filed 2020-12-07 | |||
| 2020-06-30 | $1.88M 10-Q · filed 2020-08-12 | $3.51M derived: sum of 2 quarters · filed 2021-05-14 | $4.72M 10-Q · filed 2020-08-12 | $6.10M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2020-03-31 | $1.63M 10-Q · filed 2021-05-14 | $2.84M 10-Q · filed 2021-05-14 | $4.22M derived: sum of 3 quarters · filed 2021-05-14 | $5.54M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $1.21M 10-Q · filed 2021-02-16 | $2.59M derived: sum of 2 quarters · filed 2021-02-16 | $3.92M derived: sum of 3 quarters · filed 2021-02-16 | $4.46M derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-09-30 | $1.38M derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | $2.70M derived: sum of 2 quarters · filed 2020-12-07 | $3.24M 10-K · filed 2020-12-07 | $3.65M derived: sum of 4 quarters · filed 2020-12-07 | |||
| 2019-06-30 | $1.32M 10-Q · filed 2020-08-12 | $1.86M 10-Q · filed 2019-08-14 | $2.27M 10-Q · filed 2020-08-12 | $2.63M derived: sum of 4 quarters · filed 2020-08-12 | |||
| 2019-03-31 | $540.78K 10-Q · filed 2020-05-15 | $1.80M 10-Q · filed 2019-05-08 | $946.52K 10-Q · filed 2020-05-15 | $3.26M 10-Q · filed 2019-05-08 | $1.31M derived: sum of 3 quarters · filed 2020-05-15 | $1.73M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $405.74K 10-Q · filed 2020-02-13 | $1.46M 10-Q · filed 2019-02-05 | $765.36K derived: sum of 2 quarters · filed 2020-02-13 | $1.19M derived: sum of 3 quarters · filed 2020-02-13 | $1.62M 10-KT · filed 2019-12-12 | ||
| 2018-09-30 | $359.62K derived: 10-KT 9 month − 10-Q 6 month · filed 2019-12-12 | $781.61K derived: sum of 2 quarters · filed 2019-12-12 | $1.21M 10-KT · filed 2019-12-12 | $5.29M 10-K · filed 2018-11-30 | |||
| 2018-06-30 | $421.99K 10-Q · filed 2019-08-14 | $1.23M 10-Q · filed 2018-08-08 | $853.29K 10-Q · filed 2019-08-14 | $4.05M 10-Q · filed 2018-08-08 | $4.61M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $1.41M 10-Q · filed 2019-05-08 | $2.82M 10-Q · filed 2019-05-08 | $4.19M derived: sum of 3 quarters · filed 2019-05-08 | $5.50M derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $1.41M 10-Q · filed 2019-02-05 | $2.78M derived: sum of 2 quarters · filed 2019-02-05 | $4.10M derived: sum of 3 quarters · filed 2019-02-05 | $5.31M derived: sum of 4 quarters · filed 2019-02-05 | |||
| 2017-09-30 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $2.69M derived: sum of 2 quarters · filed 2018-11-30 | $3.90M derived: sum of 3 quarters · filed 2018-11-30 | $5.45M 10-K · filed 2018-11-30 | |||
| 2017-06-30 | $1.31M 10-Q · filed 2018-08-08 | $2.52M derived: sum of 2 quarters · filed 2018-08-08 | $4.08M 10-Q · filed 2018-08-08 | $5.67M derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2017-03-31 | $1.21M 10-Q · filed 2018-05-07 | $2.77M 10-Q · filed 2018-05-07 | $4.36M derived: sum of 3 quarters · filed 2018-05-07 | $5.73M derived: sum of 4 quarters · filed 2018-05-07 | |||
| 2016-12-31 | $1.56M 10-Q · filed 2018-02-07 | $3.15M derived: sum of 2 quarters · filed 2018-02-07 | $4.52M derived: sum of 3 quarters · filed 2018-02-07 | $5.94M derived: sum of 4 quarters · filed 2018-02-07 | |||
| 2016-09-30 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $2.96M derived: sum of 2 quarters · filed 2017-12-01 | $4.38M derived: sum of 3 quarters · filed 2017-12-01 | $6.18M 10-K · filed 2017-12-01 | |||
| 2016-06-30 | $1.37M 10-Q · filed 2017-08-09 | $2.79M derived: sum of 2 quarters · filed 2017-08-09 | $4.59M 10-Q · filed 2017-08-09 | $5.74M derived: sum of 4 quarters · filed 2017-12-01 | |||
| 2016-03-31 | $1.42M 10-Q · filed 2017-05-09 | $3.22M 10-Q · filed 2017-05-09 | $4.37M derived: sum of 3 quarters · filed 2017-12-01 | $5.40M derived: sum of 4 quarters · filed 2017-12-01 | |||
| 2015-12-31 | $1.80M 10-Q · filed 2017-02-06 | $2.94M derived: sum of 2 quarters · filed 2017-12-01 | $3.98M derived: sum of 3 quarters · filed 2017-12-01 | $5.35M derived: sum of 4 quarters · filed 2017-12-01 | |||
| 2015-09-30 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $2.18M derived: sum of 2 quarters · filed 2017-12-01 | $3.56M derived: sum of 3 quarters · filed 2017-12-01 | $5.10M 10-K · filed 2017-12-01 | |||
| 2015-06-30 | $1.03M 10-Q · filed 2016-08-09 | $2.41M derived: sum of 2 quarters · filed 2016-08-09 | $3.95M 10-Q · filed 2016-08-09 | ||||
| 2015-03-31 | $1.38M 10-Q · filed 2016-05-09 | $2.92M 10-Q · filed 2016-05-09 | |||||
| 2014-12-31 | $1.54M 10-Q · filed 2016-02-08 | ||||||
| 2014-09-30 | $505.11K 10-K · filed 2016-12-14 | ||||||
| 2014-08-31 | $6.09M 10-K · filed 2016-12-14 | ||||||
| 2014-06-30 | $1.34M 10-Q · filed 2015-08-10 | $2.90M derived: sum of 2 quarters · filed 2015-08-10 | $4.65M 10-Q · filed 2015-08-10 | ||||
| 2014-03-31 | $1.56M 10-Q · filed 2015-05-11 | $3.31M 10-Q · filed 2015-05-11 | |||||
| 2013-12-31 | $1.75M 10-Q · filed 2015-02-09 | ||||||
| 2013-09-30 | $351.19K 10-Q · filed 2015-02-09 | ||||||
| 2013-08-31 | $4.39M 10-K · filed 2015-12-14 | ||||||
| 2012-08-31 | $6.83M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |